Latest filing published 14 Apr 2021 for KYTO BIOPHARMA INC, €5,015.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Georges Benarroch discloses dealings in 3 companies, chiefly Osprey Gold Corp, Kyto Biopharma Inc and Freedom Holding Corp. We count 17 filings; the first trade dates from 21 December 2005 and the latest from 16 March 2021.
The open-market record is one-sided, with 4 purchases worth €57k and not one sale. The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 7 share grants and 1 option exercise.
The newest entry dates from 14 April 2021: an option exercise of €5,015, in Kyto Biopharma Inc. The last insider purchase was made public on 14 January 2014, 4,665 days ago. Typically, a trade is published a median of 28 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations